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It has been shown earlier in an in-vitro model of inflammatory islet cell death that activated maerophages l yse islet cells via the release of nitric 
oxide. Here we report hat cyelosporin A suppresses macrophage cytotoxicity. Comrol cxperiments showed that the immunosuppressive drug does 
not improve the defenees of islet cells against nitric oxide but inhibits the release of nitric oxide from LPS.stimulated macrophages. This property 
of cyclosporin A may contribute to tbe preservation ol'fl cell function ~een in cyclosporln A-treated patients with recent onset type I diabetes. 
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1. INTRODUCTION 
The progressive destruction of insulin-producing 
cells during the development of type I diabetes ha~ been 
discussed to result from the attack of cytotoxie T-cells 
as well as from toxic product~ of inflammatory macro- 
phages such as interleukin I, oxygen radicals and nitric 
oxide [1-4]. The largely T-cell specili¢ immunosuppres- 
sent cyclosporin A was found to extend the remission 
pha~e [5,6] and to preserve ,fl cell fttnetion [5] in patients 
with recent onset diabetes. 
In the pre-'~ent study we tested the hypothesis that 
cyclosporin A may not only interfere with T-cell reac- 
tions but also act on islet-toxic macrophages. For this 
purpose we used an in-vitro model ef  islet ceil lysiz by 
activated macrophages [7]. In this model islet cell death 
is due to the release of nitric oxide by macrophages [4]. 
We describe here that the addition of cyclo~porin A to 
the incubation system inhibits macrophage cytotoxicity 
towards pancreatic islet cells. 
2. MATERIALS AND METHODS 
2.1 l~'let cella 
Pancreatic islets were isolated from 3- to 4.months-old Wistar rats 
of our own colony by dactal injection of colla8ena~e (Serve, Hei- 
delberg, Germany). density l~radient centrifulgation a d handpicking 
as described previously [7]. Single cell suspensions were prepared by 
trypsin treatment followed by 18 h cultured at 37°C/5% CO: lbr 
recovery in enriched RPMI 1640 containing 4 mM glucose, ampieillit~ 
25 me/I, penicillin 120 rag/l, streptomycin 270 m~l, sodium pyravate 
I raM, L-81utamine 2 mM, non-e~sential amino aeid~ 1×, NaHCO.~ 2 
g/l, HEPES 2.38 g/l and 10% FCS (Gibco BRL, Heidelberg) [7]. 
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2.2 Macrophages 
Peritoneal macrophages were activated by injection of Os.vne- 
bacterl,m/tort,urn suspension (Wellcome, Burgwedel, Germany) i.p. 
5 days prior to isolat iota [7]. Maerophages were enviet:cd by adherence 
to FCS-ct~ated Pel ri dishes, wasbe~ and detachmen! by Ca~+/Mg-~+-free 
HBSS at 4°C. As determined earlieJ' by immtmocytoehemistry and
dectron microscopy, between 92-95% of the ~dherent cells could be 
positively identified as macrophages [7,8]. For the analysis of inducible 
NO production t0 ~ macrophages were seeded in 100,ul per well in 
round.bottom 96-well mierottter plate~. Serial dilutions ofeyelosporin 
A (50,ul, Sandimman, Sandoz, Ba~el, Switzerland) were added. In a 
set of samples macrophages were stimulated with 50 ,ttl lipopolysac- 
charide solution (LPS fi'om Escherichia coli 026:B6, Sigma, final con- 
centration I n ,g/ml). After 20 h at 37°C/5% CO.,, 150,ttl of the super- 
natants were collected and the accumulated nitrite determined by the 
Oriess reaction [9]. The resulting extinctions were converted to NOZ. 
concentration,~ using a standard curve obtained wilh NaNO~. 
2.3. Cj,tot~xicitj, assay.~' 
For macrophage-i~let c ll co-culture xperiments i51cl cells were 
labelled by [al-i]leucine for 20 h as described [7]. Radiolabelted islet 
cells (5 × 10 ~ cells in 100 ,ul) were mixed with It00 #1 of maerophages 
(5 × 10 '* - 2 × 10 ~ cells) and incubated in round-bottom 96-well mi- 
crotiter platen for 16 h at 37°C/5% CO~. The radiolabel was deter- 
mined in 100 t21 of mtpernatant. The spontaneous release of ~H was 
l¢.t~ than 30% and subtracted from all experimental valtte,~, Az shown 
before, the release of radiolabel correlates closely, with ly~is of islet 
cells, as determined by electron microscopy [7]. 
For the analysis of NO toxicity i~let cells were seeded in half area 
round bottom microtiter plates at 2 × 10 '~ cell~120 ~1 per well. After 
preincubation for 3 h the NO-donor nitroprusside (Merck, Darm- 
stadt, Germany) or S.nitroso-N-acetyl-penieillamine (SNAP) (kind 
gift of Prof. E. No.'tck, University of Dtisseldorf, D~s.~eldorf, Ger- 
many) were added. Cyanide ions released by nitroprusside were scav- 
enged by the addition of 8 U rhodanese (Sigma, Stelnhehn, Germ~my) 
and 5 mM Na:$_~Os. After illeubation for 16 h at 37°C/5% CO~ cell 
viability determined by Trypan blue eaclusion. At lea~t 200 cells per 
well were counted [10]. 
2.4. Statistics 
Differences between mean values were analysed by Student's t-teat, 
two sidexl. 
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3. RESULTS 
The lysis of islet cells seen after co-culture with acti- 
vated macrophages was dependent on the tar- 
of 20 (Fig. l.l, The addition o1" c.vclosoorin A to the 
incubation mixture inhibited islet cell lysis. A concen- 
tration of 1 ~g/ml was effective at all T:E ratios while 
a dose of 0.2 pg/ml was only inhibitory at the T:E ratios 
of 1:10 and 1:20 (Fig. 1). The addition of the NO syn- 
thase antagonist N°-monomethyl-L-arginin¢ completely 
inhibited islet cell lysis, demonstrating that macrophage 
tric oxide pathway. In controls no effect of cyclosporin 
A on the viability of the macrophages could be detected, 
Even at a concentration r 5/,tg/ml ey¢losporin A the 
Trypan blue exclusion assay revealed 97.7 _.+ 0.2% 
(mean +_. S.D. from three exneftn~ents) living cells allter 
16 h of incubation. This corresponds tothe survival rate 
c(actcreated el& (98.4 +_ ~ A%~. 
Next we tested whether the protective action or cy- 
closporin A occurs on the level of the islet cell, I~{et ceils 
were preincubated for 3 It with cyclosporin A and subse- 
quently exposed to chemical NO-donors. No protection 
from NO-toxicity was noted in the presence of ¢y- 
In a third series of experiments it was determined 
whether cyclosporin A interferes with the arginine de- 
pendent eytotoxicity pathway of macrophages, As 
shown in Fig. 3 incubation of peritoneal macrophages 
with LPS for 20 h stimulated the release of nitrite which 
was "mh'tb~tab~e by cyc~ospor'ttz A and by ~'¢%motzo- 
methyl.r-arginine. 
As shown in Figs. 1 and 2 the concentrations of the 
NO-donors nitroprusside and SNAP were chosen to 
yield similar amounts of lysis as obtained from macro- 
phages. However, the nitrite concentration in the super- 
natant of maerophages cannot be directly compared 
with the concentration of chemical NO-donors. Our 
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Fi~. 1. Inhibition of maeropltage cytotoxieity towards islet ¢¢11s I)7 
cyclosporin A or N-methyl-arginioe. Shown are mean values ± S,D. 
0' = 6), Statistical differences between islet cell t/sis in the absence or 
presence of pharmacological inhibitors are indicated az *P < 0,05: 
**P < 0,01; ***P<0.001. 
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Fig. 2, C),clo~porin A does not inhibit NO toxicity in islet ee][~. Islet 
ceils were inettbat~d for16 h with medium (control). 0 5 mM nitro- 
prus~ide or0.4 mM SNAP. Shown are m¢~tn values _+ S.D. (t~ = 4). 
own unpublished observations and results from Feel- 
iseh et al. [11] showed that the concentration of an 
NO-donor may not correlate with its NO-releasing ca- 
pacity. Furthermore, depending on the NO-generating 
substance, highly variable amounts of NO may be oxi- 
dized to nitrite. On the other hand, macrophage prod- 
ucts may influence the formation of nitrite from NO. 
4. DISCUSSION 
The immunosuppressive drug cyclosporin A has been 
shown earlier to interfere with a calcium.sensitive T-cell 
signal transduction pathway involving calcineurin 
[12,13], In addition, cyclosporin A inhibits macrophage 
accessory function which also may suppress T-cell acti- 
vation [14]. 
The data presented here indicate that cyclosporin A
at pharmacological doses interferes with the arginine- 
dependent cytotoxicity pathway of macrophages. This 
conclusion isbased on two difl'erent observations. First~ 
cyclosporin A suppresses the cytotoxic action of acti- 
vated macrophages against pancreatic islet cells. The 
arginine-dependence of the iytic event has been previ- 
ously demonstrated [4] and is confirmed here by the 
protection of islet cell lysis in the presence of the NO 
synthase inhibitor N°-monomethyl-L-arginine. Second 
the accumulation of nitrite in the supernatant of LPS- 
stimulated macrophages is reduced in the presence of 
cyclosporin A, indicating the suppression of arginine- 
dependent NO formation. On the other hand. cy- 
closporin A failed to prevent islet cell lysis induced by 
chemical NO donors in the absence of effector cells. 
This finding also indicates, that the drug does not act 
by protecting islet cells from NO toxicity but suppresses 
the NO mediated cytotoxic activity of nmcrophages. 
Since the macrophage c ll suspension contained a negli- 
gible quantity of T-cells it is reasonable to assume that 
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Fie,. 3. Inhibition of nitrite release front activated macrophages by 
cyclosporin A or N-methyl.ar£ininc. The incubation with LPS induced 
3.22 nnaol ",- 0.33 of nitrite per 10 ~ macrophag¢,~ per well (n = 4) 
(l~aekground nitrite levels subtracted) in the experimetlts with eyelo- 
sporin A and 7.47 nmol_  3.28 in the ¢.~perimenta with N cs- 
monomethyl-t.-ar,~inine (NMA). Shown are mean values __. S.D. 
(n = 4), 
the suppressive effect of cyclosporin A is due to direct 
interaction with the macrophage. 
Interestingly. FKS06, an immunosuppressive agent 
with similar mechanisms of action as cyclosporin A 
[15,16], was found to exert comparable ffects in a 
model of allograft rejection. FK506 prolonged the sur- 
vival of allogeneic grafts [17] obviously by inhibiting 
NO-formation from maerophages infiltrating the graft 
[17,181. 
The production of NO by macrophages requ:,~'es prior 
activation by appropriate stimuli such as LPS ro cause 
synthesis of the inducible NO synthase [19]. Similar as 
in T-cells, cyclosporin A may prevent the activation of 
specific transcription factors. Another stimulant in- 
duced response of maeropha/~es, the phorbol ester-de- 
pendent respiratory burst also was found reduced in the 
presence of cyclosporin A [20]. Furthermore~ ey- 
elosporin A was found to inhibit the acquisition of tu- 
moricidal properties by macrophages activated with ei- 
ther macrophage activation factor in combination with 
lipopolysaccharide or the calcium ionophore A23187 
[21]. A recent report described the inhibition by cy- 
closporin A of stimulant induced superoxide produc- 
tion from polymorphonuelear leukocytes [22]. Taken 
together, these data imply that cyelosporin A may inter- 
fere with signal transduction pathway also in other leu- 
kocytes than T-cells. 
The suppression of arginine-dependent macrophage 
cytotoxicity may account in part for the preservation of 
beta cell function seen in patients with acute type I 
diabetes receiving cyclosporin A [5]. Islet cells have been 
shown previously to have a poor defence against free 
radicals [23] and to be highly susceptible to the arginine- 
dependent lytic activity of inflammatory maerophages 
[4,7]. Interference by cyclosporin A with NO and oxy- 
gen radical production from islet infiltrating inflamma- 
tory maerophages ean be expected to support ,8 cell 
survival. 
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